World Drugs for Toxoplasmosis Market by Product Type, Market, Players and Regions-Forecast To 2024 (Covering USA, EU, China, South East Asia, India, Japan and etc)

Home/World Drugs for Toxoplasmosis Market by Product Type, Market, Players and Regions-Forecast To 2024 (Covering USA, EU, China, South East Asia, India, Japan and etc)

World Drugs for Toxoplasmosis Market by Product Type, Market, Players and Regions-Forecast To 2024 (Covering USA, EU, China, South East Asia, India, Japan and etc)

Healthcare, Pharma & Healthcare

Publication ID:

ICRW02190029

Publication Date:

February 12, 2019

Pages:

103

Publisher:

ICRW

Region:

Global

$2,960.00

Need Custom Market Research Solution?

Want to commission a custom market research to suit your needs? We are here to help. Let us know.

Printer version

Send by email

PDF version

Tabs

Description

Summary

Drugs for Toxoplasmosis market research report provides the latest industry data and industry future trends, allowing you to identify the products and end users driving revenue growth and profitability. The industry report lists the leading competitors and provides the insights strategic industry analysis of the key factors influencing the market. The report includes the forecasts, analysis and discussion of important industry trends, market size, market share estimates and profiles of the leading industry Players.

Global Drugs for Toxoplasmosis Market: Product Segment Analysis
Spiramicin
Daraprim
Clindamycin
Sulfadiazine
Others
Global Drugs for Toxoplasmosis Market: Application Segment Analysis
Congenital toxoplasmosis
Acute Toxoplasmosis treatment
Others
Global Drugs for Toxoplasmosis Market: Regional Segment Analysis
USA
Europe
China
India
Japan
SEA
The Players Mentioned in our report
GSK
Pfizer
Mylan
Fresenius
Sandoz
TURING PHARMS AG
Imprimis Pharmaceuticals
Sanofi

Table of Contents

Table of Content

Chapter 1 About the Drugs for Toxoplasmosis Industry 1
1.1 Industry Definition and Types 1
1.2 Main Market Activities 3
1.3 Drug Industries 5
1.4 Industry at a Glance 5
Chapter 2 World Market Competition Landscape 6
2.1 Drugs for Toxoplasmosis Markets by regions 6
2.1.1 USA 6
USA Market Revenue and Growth Rate 6
2.1.2 Europe 9
Europe Market Revenue and Growth Rate 9
Market overview 9
Europe Clindamycin Drugs for Toxoplasmosis Major Players Revenue in 2018 10
2.1.3 China 10
China Market Revenue and Growth Rate 10
Market overview 11
China Major Players in 2018 11
2.1.4 India 12
India Market Revenue and Growth Rate 12
Market overview 13
2.1.5 Japan 16
Japan Market Revenue and Growth Rate 16
Market overview 16
2.1.6 South East Asia 16
South East Asia Market Revenue and Growth Rate 16
Market overview 16
2.2 World Drugs for Toxoplasmosis Market by Types 17
Spiramicin 17
Daraprim 17
Clindamycin 17
Sulfadiazine 17
2.3 World Drugs for Toxoplasmosis Market by Applications 21
Congenital toxoplasmosis 21
Acute Toxoplasmosis 21
2.4 World Drugs for Toxoplasmosis Market Analysis 25
2.4.1 World Drugs for Toxoplasmosis Market Revenue and Growth Rate 2014-2018 25
Chapter 3 World Drugs for Toxoplasmosis Market share 30
3.1 World Revenue Market share by Major Players 30
3.2 Major Regions Market Price in 2018 31
3.3 Major Regions Market share By Revenue in 2018, Through 2024 32
3.5 Revenue (M USD) and Market share By Types in 2018, Through 2024 37
Chapter 4 Supply Chain 39
4.1 Industry Supply chain Analysis 39
4.2 Raw material Market analysis 39
4.2.1 Raw material Prices analysis 2014-2018 40
4.2.2 Raw material Supply Market analysis 40
4.3 Manufacturing Equipment Suppliers Analysis 41
4.4 Production Process Analysis 43
4.5 Production Cost Structure Benchmarks 45
Chapter 5 Company Details (Foundation Year, Employee Strength and etc)s 58
5.1 GSK 58
5.1.1 Company Profile 58
5.1.2 Product Information 59
5.1.3 Revenue, Cost, Gross and Gross Margin 60
5.2 Pfizer 60
5.2.1 Company Profile 60
5.2.2 Product Information 62
5.2.3 Revenue, Cost, Gross and Gross Margin 63
5.3 Sanofi 63
5.3.1 Company Profile 63
5.3.2 Product Information 64
5.3.3 Revenue, Cost, Gross and Gross Margin 65
5.4 Mylan 65
5.4.1 Company Profile 65
5.4.2 Product Information 66
5.4.3 Revenue, Cost, Gross and Gross Margin 67
5.5 Sandoz (Novartis AG) 67
5.5.1 Company Profile 67
5.5.2 Product Information 68
5.5.3 Revenue, Cost, Gross and Gross Margin 69
5.6 Fresenius Kabi 70
5.6.1 Company Profile 70
5.6.2 Product Information 71
5.6.3 Revenue, Cost, Gross and Gross Margin 72
5.7 TURING PHARMS AG 72
5.7.1 Company Profile 72
5.7.2 Product Information 74
5.7.3 Revenue, Cost, Gross and Gross Margin 74
5.8 Imprimis Pharmaceuticals 75
5.8.1 Company Profile 75
5.8.2 Product Information 76
5.8.3 Revenue, Cost, Gross and Gross Margin 76
Chapter 6 Globalisation & Trade 77
6.1 Business Locations 77
6.2 Supply Channels 79
6.3 Marketing strategy 79
6.3.1 Pricing Strategy 79
6.3.2 Brand Strategy 80
6.4 Barriers to Entry 83
Chapter 7 Distributors and Customers 84
7.1 Major Distributors and contact information 84
7.2 Customer and Toxoplasmosis Information 84
Chapter 8 Import, Export, Supply and Consumption Value by Major Countries 87
8.1 USA 87
8.2 Germany 87
8.3 China 87
8.4 Japan 88
8.5 India 88
Chapter 9 World Drugs for Toxoplasmosis Market Forecast through 2024 89
9.1 World Drugs for Toxoplasmosis Revenue (by Regions, Types, Applications) Forecast through 2024 89
9.4 World Drugs for Toxoplasmosis Market Analysis 99
Chapter 10 Key success factors and Market Conclusion 100
Source List 101
Disclosure Section 101
Research Methodology 102
Data Source 103
Disclaimer 103

Tables and figures
Figure Picture of Drugs for Toxoplasmosis 2
Table Product Specifications of Drugs for Toxoplasmosis 2
Table Main Market Activities by Regions 3
Figure 2018 Generic Drugs Revenue Share by Manufacturers 5
Table USA Daraprim Drugs for Toxoplasmosis Market Revenue and Growth Rate 2014-2018 6
Figure USA Daraprim Drugs for Toxoplasmosis Market Revenue Share by Competitors 2018 7
Table USA Clindamycin Drugs for Toxoplasmosis Revenue and Growth rate in 2018 8
Figure USA Clindamycin Drugs for Toxoplasmosis Revenue Share in 2018 8
Table Europe Spiramycin Drugs for Toxoplasmosis Market Revenue and Growth Rate 9
Table Europe Clindamycin Drugs for Toxoplasmosis Market Revenue and Growth Rate 9
Table Europe Clindamycin Drugs for Toxoplasmosis Major Players Revenue in 2018 10
Table China Sulfadiazine Drugs for Toxoplasmosis Market Revenue and Growth Rate 10
Table China Spiramycin Drugs for Toxoplasmosis Market Revenue and Growth Rate 11
Table China Pyrimethamine Drugs for Toxoplasmosis Market Revenue and Growth Rate 11
Table China Sulfadiazine Drugs for Toxoplasmosis Major Players 11
Table China Pyrimethamine Drugs for Toxoplasmosis Major Players 11
Table China Spiramycin Drugs for Toxoplasmosis Major Suppliers 12
Table India Daraprim Drugs for Toxoplasmosis Market Revenue and Growth Rate 12
Table India Daraprim Drugs Brand and Manufacturers 13
Table India price for Daraprim 15
Table Japan Drugs for Toxoplasmosis Market Revenue and Growth Rate 16
Table South East Asia Market Revenue and Growth Rate 16
Table Global Drugs for Toxoplasmosis Revenue Share by Types 2014-2018 17
Table Global Drugs for Toxoplasmosis Revenue by Types 2014-2018 17
Figure 2014 Global Drugs for Toxoplasmosis Revenue Share by Type 18
Figure 2014 Global Drugs for Toxoplasmosis Revenue Share by Type 18
Figure 2013 Global Drugs for Toxoplasmosis Revenue Share by Type 19
Figure 2014 Global Drugs for Toxoplasmosis Revenue Share by Type 19
Figure 2017 Global Drugs for Toxoplasmosis Revenue Share by Type 20
Figure 2018 Global Drugs for Toxoplasmosis Revenue Share by Type 20
Table Global Drugs for Toxoplasmosis Revenue Share by Applications 2014-2018 21
Table Global Drugs for Toxoplasmosis Revenue by Applications 2014-2018 21
Figure 2014 Global Drugs for Toxoplasmosis Revenue Share by Applications 22
Figure 2014 Global Drugs for Toxoplasmosis Revenue Share by Applications 22
Figure 2013 Global Drugs for Toxoplasmosis Revenue Share by Types 23
Figure 2014 Global Drugs for Toxoplasmosis Revenue Share by Applications 23
Figure 2017 Global Drugs for Toxoplasmosis Revenue Share by Applications 24
Figure 2018 Global Drugs for Toxoplasmosis Revenue Share by Applications 24
Figure World Drugs for Toxoplasmosis Market Revenue (M USD) and Growth Rate 2014-2018 25
Figure USA Drugs for Toxoplasmosis Market Revenue (M USD) and Growth Rate 2014-2018 26
Figure Europe Drugs for Toxoplasmosis Market Revenue (M USD) and Growth Rate 2014-2018 26
Figure ASIA Drugs for Toxoplasmosis Market Revenue (M USD) and Growth Rate 2014-2018 27
Figure China Drugs for Toxoplasmosis Market Revenue (M USD) and Growth Rate 2014-2018 27
Figure India Drugs for Toxoplasmosis Market Revenue (M USD) and Growth Rate 2014-2018 28
Figure Japan Drugs for Toxoplasmosis Market Revenue (M USD) and Growth Rate 2014-2018 28
Figure SEA Drugs for Toxoplasmosis Market Revenue (M USD) and Growth Rate 2014-2018 29
Table Revenue Market share by Major Players 2018 30
Table Revenue Market share by Major Players 2017 30
Table Revenue Market share by Major Players 2018 31
Table Major Regions Pyrimethamine Price in 2018 31
Figure Drugs for Toxoplasmosis Price (USD/Unit) by Competitors 2017 32
Table Major Regions Market by Revenue in 2014-2018 32
Figure World Major Regions Market share by Revenue in 2014 33
Figure World Major Regions Market share by Revenue in 2014 33
Figure World Major Regions Market share by Revenue in 2013 34
Figure World Major Regions Market share by Revenue in 2014 34
Figure World Major Regions Market share by Revenue in 2017 35
Figure World Major Regions Market share by Revenue in 2018 35
Table Asia Major Regions Market share by Revenue in 2014-2018 36
Table Asia Major Regions Market share by Revenue in 2014-2018 36
Figure Asia Major Regions Market share by Revenue in 2014 36
Figure Asia Major Regions Market share by Revenue in 2018 37
Table Revenue (M USD) By Types in 2018-2024 37
Table Revenue (M USD) By Types in 2018-2024 37
Table Industry Supply chain Analysis 39
Table 4-Chlorobenzyl cyanide Prices analysis 2014-2018 (Chinese FOB) 40
Table 4-Chlorobenzyl cyanide Suppliers Market analysis 40
Table Key Manufacturing Equipment Analysis 41
Figure Pyrimethamine Preparing Process Analysis 43
Figure Drug Preparing Process Analysis 44
Figure Manufacturing Cost Structure of Bacterial Vaginosis Drug 45
Table GSK Company Profile 58
Figure Drugs for Toxoplasmosis Product Information of GSK 59
Table Drugs for Toxoplasmosis Cost (M USD), Gross (M USD), Revenue (M USD), Gross Margin and Revenue Share of GSK (2017 and 2018) 60
Table Pfizer Company Profile 60
Figure Drugs for Toxoplasmosis Product Information of Pfizer 62
Table Drugs for Toxoplasmosis Cost (M USD), Gross (M USD), Revenue (M USD), Gross Margin and Revenue Share of Pfizer (2017 and 2018) 63
Table Sanofi Company Profile 63
Figure Drugs for Toxoplasmosis Spiramycin Product Information of Sanofi 64
Table Drugs for Toxoplasmosis Cost (M USD), Gross (M USD), Revenue (M USD), Gross Margin and Revenue Share of Sanofi (2017 and 2018) 65
Table Mylan Company Profile 65
Figure Drugs for Toxoplasmosis Product Information of Mylan 66
Table Drugs for Toxoplasmosis Cost (M USD), Gross (M USD), Revenue (M USD), Gross Margin and Revenue Share of Mylan (2017 and 2018) 67
Table Sandoz (Novartis AG) Company Profile 67
Figure Drugs for Toxoplasmosis Product Information of Sandoz (Novartis AG) 68
Table Drugs for Toxoplasmosis Cost (M USD), Gross (M USD), Revenue (M USD), Gross Margin and Revenue Share of Sandoz (Novartis AG) (2017 and 2018) 69
Table Fresenius Kabi Company Profile 70
Figure Drugs for Toxoplasmosis Product Information of Fresenius Kabi 71
Table Drugs for Toxoplasmosis Cost (M USD), Gross (M USD), Revenue (M USD), Gross Margin and Revenue Share of Fresenius Kabi (2017 and 2018) 72
Table TURING PHARMS AG Company Profile 72
Figure Drugs for Toxoplasmosis Product Information of TURING PHARMS AG 74
Table Drugs for Toxoplasmosis Cost (M USD), Gross (M USD), Revenue (M USD), Gross Margin and Revenue Share of TURING PHARMS AG (2017 and 2018) 74
Table Imprimis Pharmaceuticals Company Profile 75
Figure Drugs for Toxoplasmosis Product Information of Imprimis Pharmaceuticals 76
Table Drugs for Toxoplasmosis Cost (M USD), Gross (M USD), Revenue (M USD), Gross Margin and Revenue Share of Imprimis Pharmaceuticals (2017 and 2018) 76
Table Clindamycin Major Manufacturers Business Locations 77
Table Pyrimethamine Business Locations 77
Table Sulfadiazine Suppliers Business location 78
Table Spiramycina Business location 78
Figure Supply Channels 79
Table Major Distributors and contact information 84
Table Major Buyers of Drugs for Toxoplasmosis 84
Table USA Supply, Import, Export, and Consumption Value(M USD) 87
Table Germany Supply, Import, Export, and Consumption Value(M USD) 87
Table China Supply, Import, Export, and Consumption Value(M USD) 87
Table Japan Supply, Import, Export, and Consumption Value(M USD) 88
Table India Supply, Import, Export, and Consumption Value(M USD) 88
Table World Revenue (M USD) by Regions Forecast Analysis of Drugs for Toxoplasmosis (2018-2024) 89
Figure World Revenue (M USD) by Regions Forecast Analysis of Drugs for Toxoplasmosis 2017 90
Figure World Revenue (M USD) by Regions Forecast Analysis of Drugs for Toxoplasmosis 2018 90
Figure World Revenue (M USD) by Regions Forecast Analysis of Drugs for Toxoplasmosis 2019 91
Figure World Revenue (M USD) by Regions Forecast Analysis of Drugs for Toxoplasmosis 2020 91
Figure World Revenue (M USD) by Regions Forecast Analysis of Drugs for Toxoplasmosis 2024 92
Table Asia Revenue (M USD) by Regions Forecast Analysis of Drugs for Toxoplasmosis (2018-2024) 92
Figure Asia Revenue (M USD) by Regions Forecast Analysis of Drugs for Toxoplasmosis 2017 93
Figure Asia Revenue (M USD) by Regions Forecast Analysis of Drugs for Toxoplasmosis 2018 93
Figure Asia Revenue (M USD) by Regions Forecast Analysis of Drugs for Toxoplasmosis 2019 94
Figure Asia Revenue (M USD) by Regions Forecast Analysis of Drugs for Toxoplasmosis 2020 94
Figure Asia Revenue (M USD) by Regions Forecast Analysis of Drugs for Toxoplasmosis 2024 95
Figure Revenue (M USD) By Types in 2018 95
Figure Revenue (M USD) By Types in 2017 96
Figure Revenue (M USD) By Types in 2018 96
Figure Revenue (M USD) By Types in 2019 97
Figure Revenue (M USD) By Types in 2020 97
Figure Revenue (M USD) By Types in 2024 98
Figure World Revenue (M USD) by Applications Forecast Analysis of Drugs for Toxoplasmosis 2017 98
Figure World Revenue (M USD) by Applications Forecast Analysis of Drugs for Toxoplasmosis 2024 99
Table World Drugs for Toxoplasmosis Market Revenue (M USD) and Growth Rate 2018-2024 99

Report License Types

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

Report Enquiry

Do you need more information about this report before making a purchase decision or wish to customize this report to suite your requirements?

If yes, then please use the form given below and we will get in touch with you immediately.

Kindly use your official email address and contact number to ensure speedy response.

Name *

Email *

Company

Contact Number *

Report Title *

Your Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Drag or click the correct shape to the grey "drop area".